XML 82 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition - Schedule of Revenues from Major Customers (Details) - Revenue Benchmark [Member] - Product Concentration Risk [Member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Largest Customer | HEPLISAV-B      
Concentration Risk [Line Items]      
Percentage of product revenue 21.00% 21.00% 21.00%
Second Largest Customer | HEPLISAV-B      
Concentration Risk [Line Items]      
Percentage of product revenue 17.00% 19.00% 20.00%
Third Largest Customer | HEPLISAV-B      
Concentration Risk [Line Items]      
Percentage of product revenue 16.00% 19.00% 20.00%
Largest Collaboration Partner | CpG 1018      
Concentration Risk [Line Items]      
Percentage of product revenue 49.00% 49.00% 62.00%
Second Largest Collaboration Partner | CpG 1018      
Concentration Risk [Line Items]      
Percentage of product revenue 35.00% 24.00% 36.00%
Third Largest Customer | CpG 1018      
Concentration Risk [Line Items]      
Percentage of product revenue 12.00% 19.00% 2.00%